Relationship between O6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients

Canadian Journal of Neurological Sciences

Volumn 26, Issue 2, 1999, Pages 104-109

  Chen, Zhong Ping ^e   Yarosh, Daniel ^c   Garcia, Yesenia ^c   Tampieri, Donatella ^a   Mohr, Gérard ^e   Malapetsa, Areti ^e   Langleben, Adrian ^b   Panasci, Lawrence C ^d  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c GenQuest Incorporated   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CHLOROETHYLNITROSOUREA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROCARBAZINE; VINCRISTINE; ANTINEOPLASTIC AGENT; DNA METHYLTRANSFERASE; DRUG DERIVATIVE; GUANINE; N (2 CHLOROETHYL) N NITROSOACETAMIDE; N-(2-CHLOROETHYL)-N-NITROSOACETAMIDE; NITROSO DERIVATIVE; O (6) METHYLGUANINE; O-(6)-METHYLGUANINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PREDICTION; PRIORITY JOURNAL; AGE; BRAIN TUMOR; CELL CULTURE; DRUG RESISTANCE; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DNA MODIFICATION METHYLASES; DRUG RESISTANCE, NEOPLASM; FEMALE; GLIOMA; GUANINE; HUMANS; MALE; MIDDLE AGED; NITROSO COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0032587774     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kohn KW, Erickson LC, Laurent G, et al. DNA crosslinking and the origin of sensitivity to chloroethylnitrosourea. In: Prestayko AW, Crooke ST, Baker LH, Carter SK, Schein PS eds. Nitrosoureas. New York: Academic Press 1981; 69-83.
2. Tong WP, Kirk MC, Ludlum DB. Formation of the cross-link 1-[N3-deoxycytidyl), 2[N1-deoxyguanosinyl] ethane in DNA treated with N, N′-bis (2-chloroethyl) 1-N-nitrosourea. Cancer Res 1982; 42: 3102-3105.
3. 6-methylguanine-DNA methyltransferase in cell survival, mutagenesis and carcinogenesis. Mutat Res 1985; 145: 1-16.
4. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic an agents. Cancer Res 1990; 50: 6119-6129.
5. 6-alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to CCNU. Proc Natl Acad Sci USA 1985; 82: 2985-2989.
6. 6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA. Cancer Res 1992; 52: 6052-6058.
7. 6-benzyl-2′-deoxyguanosine and BCNU. Cancer Res 1996; 56: 2076-2081.
8. Erickson LC, Laurent G, Sharkey NA, et al. DNA crosslinking and monoadduct repair nitrosourea-treated human tumor cells. Nature (Lond) 1980; 288: 727-729.
9. 6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas. Cancer Res 1984; 44: 2467-2474.
10. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res 1991; 51: 3367-3372.
11. 6-methylguanine-DNA methyltranferase to resistance to 1,3-(2-chloroethyl-1-nitrosourea in human brain tumor-derived cell lines. Mol Carcinog 1995; 13: 81-88.
12. 6-benzylguanine plus BCNU. Cancer Res 97; 57: 4817-4823.
13. 6 of guanine. Cancer Treat Res 1996; 87: 123-146.
14. 6-methylguanine-DNA methyltransferase mRNA in human brain tumors. Biochim Biophys Acta 1996; 1289: 105-109.
15. 6-methylguanine-DNA methyltransferase in tumors and cells of the oligodendrocyte lineage. Can J Neurol Sci 1995; 22: 111-115.
16. Belanich M, Pastor M, Randall T, et al. Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res 1996; 56: 783-778.
17. 6-methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. J Clin Oncol 1998; 16: 3310-3315.
18. Chen Z-P, Malapetsa A, McQuillan A, et al. Evidence for nucleotide excision repair as a modifying factor of MGMT mediated innate chloroethylnitrosourea resistance in human tumor cell lines. Mol Pharmacol 1997; 52: 815-820.
19. 6-alkylguanine. Proc Natl Acad Sci USA 1990; 87: 686-690.
20. 6-methylguanine-DNA methyltransferase in individual human cells by quantitative immunofluorescence microscopy. Oncol Res 1994; 6: 129-137.
21. 6-methylguanine-DNA methyltransferase in human brain tumors detected by activity assay and monoclonal antibodies. Oncol Res 1995; 7: 49-55.
22. Ayi TC, Loh KC, Ali RB, et al. Intracellular localization of human DNA repair enzyme methylguanine-DNA methyltransferase by antibodies and its importance. Cancer Res 1992; 52: 6423-6430.
23. Marcantonio D, Hollingshead MG, Alley MC, et al. SarCNU, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts. Cancer Res 1997; 57: 3895-3898.
24. Phillips PC. Antineoplastic drug resistance in brain tumors. Neurol Clin 1991; 9: 383-404.
25. Hayes JD, Pulford DJ. The glutathione s-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Critical Rev Biochem Mol Biol 1995; 30: 445-600.
26. Tew KD, Monks A, Barone L, et al. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute drug screening program. Mol Pharmacol 1996; 50: 149-159.
27. Matsumoto T, Tani E, Yamaura I, et al. Effects of protein kinase C modulators on multidrug resistance in human glioma cells. Neurosurg 1995; 36: 565-571.
28. Nabors MW, Griffin CA, Zehnbauer BA, et al. Multidrug resistance gene (MDR1) expression in human brain tumors. J Neurosurg 1991; 75: 941-946.
29. Anderson BS, Sadeghi T, Siciliano MJ, et al. Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs. Cancer Chemother Pharmacol 1996; 38: 406-416.
30. Zeng-Rong N, Paterson J, Alpert L, et al. Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy. Cancer Res 1995; 55: 4760-4764.
31. Chen Z-P, McQuillan A, Mohr G, et al. ERCC2 gene expression and chloroethylnitrosourea resistance in human glioma cell lines. Neurosurgery 1998; 42: 1112-1119.
32. Ma L, Hoeijmakers JHJ, van der Eb AJ. Mammalian nucleotide excision repair. Biochim Biophys Acta 1995; 1242: 137-164.
33. Aboussekhra A, Wood RD. Repair of UV damaged DNA by mammalian cells and Saccharomyces cerevisiae. Curr Opin Genet Dev 1994; 4: 212-220.
34. Chu G. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem-1 994; 269: 787-790.
35. Dabholkar M, Bostick-Bruton F, Weber C, et al. ERCC-1 and ERCC-2 expression in malignant tissues from ovarian cancer patients. J Natl Cancer Inst 1992; 84: 1512-1517.